HBV infection of a wide variety of cell types has been reported, but productive infection and pathology appear to be limited to the liver. Among the many cell types found in the liver, HBV infects the hepatocyte, the major parenchymal cell.
Following infection, virus is shed from hepatocytes into the bloodstream, so that every hepatocyte may genetic cancer of liver infected.
During the peak of an infection, titers of virus in the blood may reach per cubic centimeter. Infection of hepatocytes is not typically cytopathic, and the liver pathology results from the immune response to the infected cells.
CANCER la COLON metastazic .Strigatul disperat al unei mame !
Depending genetic cancer of liver the strength of the immune response, infections may be either transient or chronic. Transient infections generally resolve in fewer than 6 months, while chronic infections genetic cancer of liver be lifelong. When a hepatocyte is infected, the viral DNA genome is transported to the nucleus, where it is converted from a relaxed circular DNA to a covalently closed circular form cccDNAwhich serves as the template for viral mRNA synthesis.
Though the coding capacity of HBV is limited, it is still capable of encoding three envelope proteins, a nucleocapsid protein, a transcriptional transactivator, and a reverse transcriptase RT.
Encoding of the reverse transcriptase, the largest HBV protein, requires almost the entire viral genome. To facilitate this, the reverse transcriptase is encoded in different translational reading frames than the genetic cancer of liver viral gene products, so that overlapping reading frames can be utilized.
Following completion of reverse transcription, the RT then synthesizes most, but not all of the second DNA strand, to recreate the partially double stranded virion DNA. Prior to completion of the second strand, nucleocapsids are packaged genetic cancer of liver viral envelopes by budding into the endoplasmic reticulum, and virions are exported from the cell.
Early after infection, and probably after division of an infected hepatocyte, extra cccDNA is synthesized, maintaining the copy number at 5 to 50 per cell.
Transmission Transmission is parenteral, requiring exposure to the blood or blood-contaminated materials of infected individuals. genetic cancer of liver
The most common mode of exposure leading to chronic infection occurs at birth when the mother is chronically infected, or during the first year of life. During this period, the risk of an infection becoming chronic is at least 90 percent.
In contrast, the risk of chronic infection in adults is greater than 10 percent. According to the CDC, the most common exposure risks in adults in the United States are sexual activity 50 percent of cases and intravenous drug abuse 15 percent of cases. Public Health Issues Prevalence The case fatality rate in adults due to acute hepatitis is about 1 percent.
According to WHO, there are now million chronically infected individuals worldwide. Of these, 60 million are expected to die prematurely of liver cancer or cirrhosis, at a rate of approximately 1 million per year 5, per year in the United States.
This does not account for new cases, which will continue to accumulate in the coming decades. Vaccines A vaccine comprised of the viral envelope proteins has been available for over 20 genetic cancer of liver. Due in part to high cost, universal vaccination was not initially feasible in many parts of the world, but lower cost genetic cancer of liver have subsequently come into use.
Testing your Genes for Cancer
Universal vaccination of school children is now in effect in the United States. In some parts of the world, especially in Africa and regions of Asia, chronic infection rates exceed 5—10 percent of the population, but vaccination has not yet been economically feasible in all of these areas, even with low-cost vaccines.
Although attempts are under way to address this problem Kane,for various reasons of cost and delivery, HBV is likely to remain a major public health problem.
On top of this problem virus del papiloma y cancer is evidence for vaccine escape mutants He et al.
Though these do not yet seem to be a major public health problem, they remain a concern even for the large pool of individuals that have already received the current vaccine. In addition, about 5 percent of vaccinated individuals fail to produce a measurable antibody response, suggesting that they also remain at risk for HBV infection.
Current Research A major goal of current research has thus been the development of therapies to cure chronically infected individuals. A problem in achieving this is that hepatocytes comprise a self-renewing population with a low turnover rate, and this population often appears to be percent infected.
This same barrier is confronted and overcome during immune clearance of transient infections, though it remains controversial how the virus is actually destroyed Guidotti et al.
However, in chronic carriers, the immune system is usually unable to mount such a response, especially in those infected as children. Some hope for better immunotherapies has however been sustained by the fact that interferon alpha administration induces genetic cancer of liver loss in about 20—30 percent of carriers Hoofnagle and Lau,typically those with adult-acquired infections.